Product correctly added to cart.

1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
View 3D

Indagoo logo

1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt

CAS: 3374-05-8

Ref. AN-AG00I6N3

1g
Discontinued
5g
Discontinued
25g
Discontinued
100mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
Synonyms:
  • [u'Acid, Nalidixic', u'Anhydrous, Nalidixate Sodium', u'Nalidixate Sodium', u'Nalidixate Sodium Anhydrous', u'Nalidixic Acid', u'Nalidixin', u'Nevigramon', u'Sodium Anhydrous, Nalidixate', u'Sodium Nalidixic Acid, Anhydrous', u'Sodium Nalidixic Acid, Monohydrate', u'Sodium, Nalidixate', u'Nalidixic acid sodium salt', u'Baktogram', u'Nalidixic acid sodium', u'3374-05-8', u'Sodium nalidixate', u'Chemiurin', u'Dixilina', u'NALIDIXATE SODIUM', u'UNII-Y7NU182221', u'Nalidixate sodium anhydrous [USAN]', u'EINECS 222-159-7', u'MFCD00064376', u'Y7NU182221', u'Win 18320', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium salt', u'Nalidixate sodium anhydrous', u'Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'CPD000326712', u'SMR000326712', u'AC1MYZ5W', u'Lopac-N-4382', u'MLS001056754', u'MLS002548848', u'Nalidixate Sodium (anhydrous)', u'SCHEMBL9743577', u'CHEMBL1255939', u'CTK8B3279', u'Sodium Nalidixic Acid, Anhydrous', u'BIN4302', u'ZX-AFC000602', u'HMS3262H15', u'HMS3714G09', u'Tox21_500837', u'ANW-42193', u'GA0875', u'AKOS024307522', u'AKOS026749975', u'API0003487', u'CCG-220674', u'CCG-222141', u'LP00837', u'WIN-183203', u'NCGC00016177-01', u'NCGC00016177-02', u'NCGC00016177-03', u'NCGC00094168-01', u'NCGC00261522-01', u'BP-12504', u'LS-95957', u'SAM002264626', u'SAM002699905', u'EU-0100837', u'FT-0634810', u'K-0042', u'N 4382', u'C-25525', u'J-009440', u'J-019311', u'sodium 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'potassium 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate', u'sodium 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid sodium', u'1-OO>>u-1,4- paragraph signthornCa-7-(1/4)x>>u-4-No u-1,8-YAa currency-3-oEEa AAENI', u'nalidixic acid', u'C12H11N2O3.Na', u'Nalidixic acid sodium salt hydrate', u'CID27477', u'CID3864541', u'NALIDIXIC ACID, SODIUM SALT HYDRATE', u'Nalidixic acid sodium salt, 98% - 1G 1g', u'1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid', u'15769-77-4']
  • 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
  • 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt (1:1)
  • Nalidixate sodium
  • Nalidixic Acid Sodium
  • Nalidixic Acid Sodium Gamma-Irradiated*Molecular
  • Sodium 1-Ethyl-7-Methyl-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxylate
  • Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
  • Sodium nalidixate
  • Win 18320-3
  • See more synonyms
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Indagoo
Long term storage:
Notes:

Chemical properties

Molecular weight:
254.2171
Formula:
C12H11N2NaO3
Purity:
98%
Color/Form:
Solid
InChI:
InChI=1S/C12H12N2O3.Na/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14;/h4-6H,3H2,1-2H3,(H,16,17);/q;+1/p-1
InChI key:
ROKRAUFZFDQWLE-UHFFFAOYSA-M
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: AN-AG00I6N3 1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".